Onconetix, Inc. SEC filings ONCO

Onconetix, Inc. has 398 filings in SEC EDGAR's recent list, going back to Jul 15, 2019. Its latest annual report, Form ARS, was filed on Oct 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (material agreement). The company's fiscal year ends on December 31.

Onconetix, Inc. SEC filings
Form Description Filed Period
425 Current report Nov 6, 2026 —
8-K Current report
Material agreement
Nov 6, 2026 Nov 4, 2026
425 Form 425 Oct 27, 2026 —
8-K Current report
Other events
Oct 26, 2026 Oct 22, 2026
DEFA14A Additional proxy material Oct 23, 2026 —
8-K Current report
Other events
Oct 23, 2026 Oct 22, 2026
425 Form 425 Oct 23, 2026 —
ARS Annual report to shareholders Oct 16, 2026 Dec 31, 2025
DEF 14A Proxy statement Oct 7, 2026 Nov 10, 2026
PRE 14A Preliminary proxy statement Sep 17, 2026 Sep 17, 2026
DEFA14A Additional proxy material Sep 14, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Sep 14, 2026 Sep 11, 2026
425 Form 425 Sep 14, 2026 —
424B3 Prospectus Sep 8, 2026 —
EFFECT Filing Sep 3, 2026 —
425 Form 425 Sep 3, 2026 —
S-1/A Amended registration statement Aug 31, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
S-1 Registration statement Aug 12, 2026 —
425 Form 425 Aug 6, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jul 29, 2026 Jul 28, 2026
425 Form 425 Jul 7, 2026 —
425 Form 425 Jun 24, 2026 —
424B3 Prospectus Jun 17, 2026 —
EFFECT Filing Jun 16, 2026 —
CORRESP Letter to the SEC Jun 15, 2026 —
UPLOAD Letter from the SEC Jun 12, 2026 —
S-1 Registration statement Jun 9, 2026 —
8-K Current report
Bylaw or fiscal year change, Other events
May 19, 2026 May 19, 2026
8-K Current report
Other events
May 14, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
424B3 Prospectus May 12, 2026 —
EFFECT Filing May 11, 2026 —
EFFECT Filing May 7, 2026 —
S-1/A Amended registration statement May 7, 2026 —
CORRESP Letter to the SEC May 7, 2026 —
POS AM Post-effective amendment no. 1 to form s-1 May 7, 2026 —
UPLOAD Letter from the SEC May 5, 2026 —
8-K Current report
Shareholder vote results
May 4, 2026 Apr 30, 2026
S-1 Registration statement Apr 28, 2026 —
8-K Current report
Officer or director change
Apr 24, 2026 Apr 20, 2026
425 Form 425 Apr 9, 2026 —
425 Form 425 Apr 2, 2026 —
425 Form 425 Mar 31, 2026 —
DEF 14A Proxy statement Mar 30, 2026 Apr 30, 2026
8-K Current report
Bylaw or fiscal year change, Other events
Mar 27, 2026 Mar 23, 2026
425 Form 425 Mar 25, 2026 —
8-K/A Amended current report
Officer or director change
Mar 25, 2026 Mar 18, 2026
8-K Current report
Officer or director change
Mar 24, 2026 Mar 18, 2026
PRE 14A Preliminary proxy statement Mar 18, 2026 Apr 30, 2026
10-K Annual report Mar 13, 2026 Dec 31, 2025
425 Current report Feb 12, 2026 —
8-K Current report
Material agreement, Other events
Feb 12, 2026 Feb 11, 2026
8-K Current report
Shareholder vote results
Feb 9, 2026 Feb 3, 2026
DEF 14A Proxy statement Jan 2, 2026 Feb 3, 2026
EFFECT Filing Dec 23, 2025 —
424B3 Prospectus Dec 23, 2025 —
CORRESP Letter to the SEC Dec 22, 2025 —
PRE 14A Preliminary proxy statement Dec 22, 2025 Dec 22, 2025
S-1/A Amended registration statement Dec 22, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 10, 2025 Dec 5, 2025
8-K Current report
Material agreement
Dec 10, 2025 Dec 6, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
424B3 Prospectus Nov 10, 2025 —
DEF 14A Proxy statement Nov 10, 2025 Dec 5, 2025
S-1 Registration statement Nov 4, 2025 —
8-K Current report Oct 29, 2025 Oct 23, 2025
PRE 14A Preliminary proxy statement Oct 29, 2025 Oct 28, 2025
S-1 Registration statement Oct 16, 2025 —
D Filing Oct 7, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Oct 3, 2025 Oct 1, 2025
8-K Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
Sep 26, 2025 Sep 22, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Sep 22, 2025 Sep 17, 2025
8-K Current report
Material agreement, New debt
Sep 4, 2025 Aug 28, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Material agreement, New debt, Officer or director change
Aug 12, 2025 Aug 6, 2025
8-K Current report
Material agreement, Officer or director change, Other events
Jul 16, 2025 Jul 16, 2025
8-K Current report
Regulation FD disclosure
Jun 16, 2025 Jun 16, 2025
10-Q Quarterly report Jun 12, 2025 Mar 31, 2025
8-K Current report
Material agreement, New debt, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jun 11, 2025 Jun 11, 2025
8-K Current report
Shareholder vote results
Jun 5, 2025 May 30, 2025
10-K Annual report Jun 2, 2025 Dec 31, 2024
8-K Current report
Material agreement, New debt, Listing notice
May 22, 2025 May 16, 2025
UPLOAD Letter from the SEC May 2, 2025 —
8-K Current report
Listing notice
Apr 30, 2025 Apr 24, 2025
DEF 14A Proxy statement Apr 30, 2025 May 30, 2025
PRER14A Revised preliminary proxy statement Apr 28, 2025 —
PRE 14A Preliminary proxy statement Apr 18, 2025 Apr 18, 2025
8-K Current report
Listing notice, Other events
Apr 18, 2025 Apr 14, 2025
8-K Current report
Other events
Apr 8, 2025 Apr 8, 2025
8-K Current report
Officer or director change
Apr 3, 2025 Mar 28, 2025
NT 10-K Notification of late filing Apr 1, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Mar 24, 2025 Mar 24, 2025
8-K Current report
Regulation FD disclosure
Mar 19, 2025 Mar 19, 2025
8-K Current report
Material agreement, Officer or director change
Feb 28, 2025 Feb 24, 2025
8-K Current report
Material agreement, New debt, Auditor change, Officer or director change
Feb 18, 2025 Feb 12, 2025
424B3 Prospectus Feb 12, 2025 —
EFFECT Filing Feb 11, 2025 —
CORRESP Letter to the SEC Feb 10, 2025 —
S-1/A Amended registration statement Feb 7, 2025 —
UPLOAD Letter from the SEC Feb 3, 2025 —
S-1 Registration statement Jan 27, 2025 —
8-K Current report
Listing notice
Jan 24, 2025 Jan 23, 2025
8-K Current report
Other events
Jan 22, 2025 Jan 15, 2025
424B3 Prospectus Dec 17, 2024 —
EFFECT Filing Dec 12, 2024 —
8-K Current report
Listing notice, Other events
Dec 12, 2024 Dec 6, 2024
CORRESP Letter to the SEC Dec 11, 2024 —
S-1/A Amended registration statement Dec 11, 2024 —
S-8 Employee stock plan registration Dec 11, 2024 —
S-1/A Amended registration statement Dec 10, 2024 —
10-Q Quarterly report Dec 10, 2024 Sep 30, 2024
8-K Current report
Material agreement
Dec 3, 2024 Nov 26, 2024
NT 10-Q Notification of late filing Nov 15, 2024 Sep 30, 2024
424B4 Prospectus Nov 15, 2024 —
EFFECT Filing Nov 12, 2024 —
CORRESP Letter to the SEC Nov 12, 2024 —
S-1/A Amended registration statement Nov 12, 2024 —
CORRESP Letter to the SEC Nov 12, 2024 —
CORRESP Letter to the SEC Nov 12, 2024 —
CORRESP Letter to the SEC Nov 12, 2024 —
S-1/A Amended registration statement Nov 12, 2024 —
UPLOAD Letter from the SEC Nov 7, 2024 —
UPLOAD Letter from the SEC Nov 7, 2024 —
S-1 Registration statement Nov 1, 2024 —
S-1 Registration statement Nov 1, 2024 —
DEF 14C Information statement Oct 31, 2024 Nov 1, 2024
8-K Current report
Auditor change
Oct 21, 2024 Oct 15, 2024
PRE 14C Preliminary information statement Oct 18, 2024 Oct 18, 2024
D Filing Oct 17, 2024 —
8-K/A Amended current report
Listing notice, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Oct 9, 2024 Sep 18, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 3, 2024 Oct 2, 2024
8-K Current report
Listing notice, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Sep 24, 2024 Sep 18, 2024
8-K Current report
Material agreement
Sep 20, 2024 Sep 19, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Sep 20, 2024 Sep 20, 2024
8-K Current report
Shareholder vote results
Sep 11, 2024 Sep 5, 2024
8-K Current report
Other events
Sep 5, 2024 Sep 4, 2024
DEFA14A Additional proxy material Sep 3, 2024 —
8-K Current report
Other events
Sep 3, 2024 Sep 3, 2024
10-Q Quarterly report Aug 29, 2024 Jun 30, 2024
NT 10-Q Form 10-q extension Aug 14, 2024 Jun 30, 2024
8-K Current report Aug 7, 2024 Aug 6, 2024
DEF 14A Proxy statement Aug 1, 2024 Sep 5, 2024
PRER14A Revised preliminary proxy statement Jul 22, 2024 —
8-K Current report
Other events
Jul 15, 2024 Jul 15, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 11, 2024 Jul 11, 2024
424B4 Prospectus Jul 3, 2024 —
EFFECT Filing Jul 1, 2024 —
CORRESP Letter to the SEC Jun 28, 2024 —
S-1/A Amended registration statement Jun 25, 2024 —
PRER14A Revised preliminary proxy statement Jun 25, 2024 —
CORRESP Letter to the SEC Jun 24, 2024 —
8-K/A Amended current report
Officer or director change
Jun 14, 2024 Jun 10, 2024
UPLOAD Letter from the SEC Jun 14, 2024 —
CORRESP Letter to the SEC Jun 13, 2024 —
8-K Current report
Officer or director change
Jun 13, 2024 Jun 8, 2024
S-1/A Amended registration statement Jun 5, 2024 —
PRER14A Revised preliminary proxy statement Jun 5, 2024 —
10-Q Quarterly report May 20, 2024 Mar 31, 2024
NT 10-Q Notification of late filing May 15, 2024 Mar 31, 2024
8-K Current report
Listing notice
May 13, 2024 May 8, 2024
UPLOAD Letter from the SEC May 10, 2024 —
CORRESP Letter to the SEC Apr 26, 2024 —
S-1/A Amended registration statement Apr 26, 2024 —
8-K Current report
Material agreement, Other events
Apr 26, 2024 Apr 24, 2024
10-K Annual report Apr 11, 2024 Dec 31, 2023
8-K Current report
Other events
Apr 8, 2024 Mar 27, 2024
NT 10-K Notification of late filing Apr 1, 2024 Dec 31, 2023
8-K/A Amended current report Mar 13, 2024 Dec 15, 2023
UPLOAD Letter from the SEC Mar 12, 2024 —
8-K/A Amended current report
Acquisition or sale of assets, Other events
Feb 27, 2024 Dec 15, 2023
S-1 Registration statement Feb 14, 2024 —
PRE 14A Preliminary proxy statement Feb 14, 2024 Feb 14, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 13, 2024 Feb 8, 2024
8-K Current report
Officer or director change
Feb 12, 2024 Feb 6, 2024
S-8 Employee stock plan registration Feb 1, 2024 —
8-K Current report
Material agreement, Unregistered share sale
Jan 29, 2024 Jan 23, 2024
8-K Current report
Officer or director change
Jan 19, 2024 Jan 17, 2024
8-K Current report
Officer or director change
Jan 12, 2024 Jan 10, 2024
8-K Current report
Officer or director change
Dec 28, 2023 Dec 21, 2023
8-K/A Amended current report
Material agreement
Dec 27, 2023 Dec 15, 2023
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
Dec 21, 2023 Dec 15, 2023
8-K Current report
Regulation FD disclosure
Dec 19, 2023 Dec 19, 2023
8-K Current report
Other events
Dec 18, 2023 Dec 18, 2023
10-Q Quarterly report Nov 17, 2023 Sep 30, 2023
NT 10-Q Notification of late filing Nov 15, 2023 Sep 30, 2023
8-K Current report
Other events
Nov 2, 2023 Nov 2, 2023
8-K Current report
Regulation FD disclosure
Oct 30, 2023 Oct 30, 2023
10-Q Quarterly report Oct 20, 2023 Jun 30, 2023
8-K Current report
Other events
Oct 18, 2023 Oct 12, 2023
8-K Current report
Officer or director change, Other events
Oct 10, 2023 Oct 4, 2023
8-K Current report
Material agreement, Unregistered share sale
Oct 3, 2023 Sep 21, 2023
8-K Current report
Listing notice
Sep 22, 2023 Sep 18, 2023
8-K Current report
Officer or director change
Sep 8, 2023 Sep 2, 2023
8-K Current report
Listing notice
Aug 28, 2023 Aug 22, 2023
8-K Current report
Officer or director change, Other events
Aug 22, 2023 Aug 16, 2023
NT 10-Q Filing Aug 15, 2023 Jun 30, 2023
8-K Current report
Other events
Aug 10, 2023 Aug 10, 2023
8-K Current report
Material agreement, Unregistered share sale
Aug 3, 2023 Aug 1, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 1, 2023 Jul 31, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ONCO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cincinnati, OH
SEC filer status
, Emerging growth company
SEC CIK
1782107
Former names
Blue Water Biotech, Inc. (until Dec 18, 2023); Blue Water Vaccines Inc. (until Apr 20, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.